Monday, January 25, 2021 9:49:06 AM
TODAYS NEWS confirms the company continues to establish significant aids for trading.
Usio, Inc. (Nasdaq: USIO), an integrated electronic payment solutions provider, announced today that its strategic partnership with leading crypto currency broker Voyager Digital Holdings, LLC (“Voyager”) has been renewed and expanded wherein Usio will now become Voyager’s exclusive provider of ACH payment solutions.
Louis Hoch, President and Chief Executive Officer of Usio, said, “We are pleased to expand our partnership with Voyager, which was initially signed in 2018. We are also extremely excited to have been chosen as the exclusive provider of their ACH electronic payment needs. Over the past few years we have supported Voyager’s meteoric growth with a wide breadth of payment facilitation technology that enables them to provide their clients both the flexibility and extended capabilities that can make transactions within the crypto-asset trading framework seamless and transparent. The exciting and fast-growing crypto markets represent a tremendous growth opportunity where our increasing expertise and comprehensive electronic payment solutions are proving to be of great value to this rapidly emerging market. Due to the strong interest in the cryptocurrency markets, our activity with Voyager is quickly on the rise, and we look forward to supporting what they expect to be another year of strong growth.”
Steve Ehrlich, Co-founder and CEO of Voyager, noted, “Since the beginning, our partnership with Usio has been beneficial for both of us. Given our exponential growth, we’re glad we selected a company with a complete range of products and services we can access. Our development team is also very happy with the knowledge and responsiveness of the Usio staff. Voyager continues to grow and we rely on great partnerships such as Usio to provide us with the technology and scalability we can be confident in as we expand.”
About Voyager Digital Holdings, LLC
Voyager Digital Holdings, LLC, an operating subsidiary of Voyager Digital Ltd. (CSE: VYGR) (OTCQB: VYGVF) (FRA: UCD2), is a crypto-asset broker that provides retail and institutional investors with a turnkey solution to trade crypto assets. Voyager offers investors best execution, data and custody services through its institutional-grade open architecture platform. Voyager was founded by established Wall Street and Silicon Valley entrepreneurs who teamed to bring a better, more transparent and cost-efficient alternative for trading crypto-assets to the marketplace.
About Usio, Inc.
Usio, Inc. (Nasdaq: USIO), a leading integrated payment solutions provider, offers a wide range of payment solutions to merchants, billers, banks, service bureaus, and card issuers. The Company operates credit, debit/prepaid, and ACH payment processing platforms to deliver convenient, world-class payment solutions and services to their clients. The strength of the Company lies in its ability to provide tailored solutions for card issuance, payment acceptance, and bill payments as well as its unique technology in the prepaid sector. Usio is headquartered in San Antonio, Texas,"
Recent VYGR News
- Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected • GlobeNewswire Inc. • 09/16/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 12:06:12 PM
- Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14 • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/29/2024 08:01:00 PM
- Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences • GlobeNewswire Inc. • 08/29/2024 11:00:00 AM
- Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 08:11:30 PM
- Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results • GlobeNewswire Inc. • 08/06/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:00:13 PM
- Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/23/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:11:23 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:10:34 PM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/09/2024 08:01:00 PM
- Voyager Therapeutics to Present at Multiple Virtual Investor Conferences • GlobeNewswire Inc. • 06/13/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 11:06:00 AM
- Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:22:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:20:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:19:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:17:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:15:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:04:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 11:05:52 AM
- Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease • GlobeNewswire Inc. • 05/16/2024 11:00:00 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM